Enveric Biosciences, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Working Capital Components
Total Assets↓-8.9% -$428K
$4M
Current Assets↓-4.0% -$173K
$4M
Cash & Equivalents
—
ST Investments
—
Receivables
—
Net PPE↓-46.6% -$171K
$197K
Goodwill
—
Intangibles↓-80.0% -$169K
$42K
Total Liabilities
—
Current Liabilities↑+8.0% +$67K
$906K
Account Payables↑+18.6% +$107K
$684K
Long-Term Debt
—
Short-Term Debt
—
Stockholders Equity↓-12.5% -$495K
$3M
Retained Earnings↓-9.5% -$10M
$-113M
Operating Lease ROU Asset
—
Operating Lease Liability
—
Accumulated Depreciation↑+30.3% +$145K
$625K
Debt Due Y1
—
Debt Due Y2
—
Total Debt Carrying Amount
—